Initial Validation of Cytokine Measurement by ELISA in Canine Feces - Open Journal of Veterinary Medicine

OJVM > Vol.3 No.6, October 2013

Open Journal of Veterinary Medicine

Volume 3, Issue 6 (October 2013)

ISSN Print: 2165-3356 ISSN Online: 2165-3364

Google-based Impact Factor: 1.38 Citations

Initial Validation of Cytokine Measurement by ELISA in Canine Feces ()

HTML

Download as PDF (Size: 205KB) PP. 282-288

DOI: 10.4236/ojvm.2013.36046 4,708 Downloads 7,889 Views Citations

Author(s)

Nathalee Prakash, Phil Stumbles, Caroline Mansfield

Affiliation(s)

.
School of Veterinary and Biomedical Sciences, Murdoch University, Perth, Australia.

ABSTRACT

Measurement of fecal cytokines has been used as a marker of intestinal inflammation in people and correlates with endoscopic findings. The aim of this study was to evaluate the use of canine-specific enzyme-linked immunosorbant assays (ELISAs) for quantification of cytokines in canine fecal samples as a non-invasive biomarker. Interleukin (IL)-6, -8, -10, -23/12p40 and TNF-a were assessed by using spiked fecal samples from 3 healthy dogs. Standard curve validation was performed, and the impact of time to freeze, duration of storage and number of freeze-thaw cycles on cytokine concentration were also examined. All the cytokines assayed could be detected, with varying accuracy. The mean coefficient of variation (CV) for all standard curves ranged from 2.95%-9.8%. The mean intra-assay CV ranged from 3.1%-11.14%, and inter-assay CV from 4.36%-18.83%. Recovery of IL-23 was poor (7.23%-17.12%), precluding further interpretation of stability studies. Mean recovery did not appear to be affected by time to freeze and repeat freeze-thaw cycles in all cytokines investigated. Recovery for all cytokines after short-term storage of 30 days at -80℃ showed a recovery of <70% or >130%. In conclusion, although fecal IL-6, -8, -10, and TNF-a could be used as biomarkers of intestinal inflammation in the dog, the quality of laboratory performance and poor recovery at lower concentrations limit their application. Bench-top and freeze-thaw stability was acceptable, and samples should ideally be analyzed within a week. Investigation involving dogs with acute and chronic inflammatory intestinal disease is required to determine the role of this methodology in a clinical setting.

KEYWORDS

Fecal Cytokines; ELISA Validation; Canine; Enteritis

Share and Cite:

Prakash, N. , Stumbles, P. and Mansfield, C. (2013) Initial Validation of Cytokine Measurement by ELISA in Canine Feces. Open Journal of Veterinary Medicine, 3, 282-288. doi: 10.4236/ojvm.2013.36046.

Cited by

[1]	Fecal supernatants from dogs with idiopathic epilepsy activate enteric neurons
	Frontiers in …, 2024

[2]	Development of Nano–Micro Fused LSPR Chip for In Situ Single-Cell Secretion Analysis
	Micromachines, 2023

[3]	Concentrations of interleukin-6, 8, 10 and tumour necrosis factor-α in the faeces of dogs with acute diarrhoea
	2019

[4]	Galectin-3 Regulates Indoleamine-2, 3-dioxygenase-Dependent Cross-Talk between Colon-Infiltrating Dendritic Cells and T Regulatory Cells and May Represent a …
	2019

[5]	Fecal galectin-1 as a potential marker for colorectal cancer and disease severity
	2019

[6]	OF ULCERATIVE COLITIS FECESNI SST2 KORELIRA SA TEŽINOM ULCEROZNOG KOLITISA
	2019

[7]	Galectin-3 regulates Indoleamine-2, 3-dioxygenase-dependent cross-talk between colon-infiltrating dendritic cells and T regulatory cells and may represent a valuable …
	2019

[8]	Fecal sST2 correlates with the disease severity of ulcerative colitis
	2019

[9]	Performance measurements on an experimental Otto/Diesel engine operating with different fuels
	2018

[10]	INCREASED IL 33 AND IL 17 IN COLORECTAL CARCINOMA PATIENTS WITH SEVERE DISEASE
	2018

[11]	Increased IL-33 And IL-17 in Colorectal Carcinoma Patients with Severe Disease
	2018

[12]	Kolorektalni karcinom: značaj koncentracija citokina u serumu i fecesu za procenu težine bolesti
	2018

[13]	Povezanost metaboličkog sindroma i imunskih parametara sa kliničkim i patohistološkim karakteristikama bolesnika sa ulceroznim kolitisom
	2018

[14]	Fecal sST2 correlates with disease severity of ulcerative colitis
	Vojnosanitetski pregled, 2018

[15]	Fecal Galectin-1 as a potential marker for colorectal cancer and disease severity Фецесни галектин-1-потенцијални маркер колоректалног карцинома и …
	2018

[16]	Fecal Galectin-3: A New Promising Biomarker for Severity and Progression of Colorectal Carcinoma
	Mediators of Inflammation, 2018

[17]	Колоректални карцином: Значај концентрација цитокина у серуму и фецесу за процену тежине болести
	2018

[18]	Measurement of TNF-α and IL-6 in canine abdominal effusions using Enzyme Linked Immunosorbent Assays
	2018

[19]	Indoleamine 2, 3-dioxygenase-dependent expansion of T-regulatory cells maintains mucosal healing in ulcerative colitis
	Therapeutic advances in gastroenterology, 2018

[20]	The mineral content of the hard dental tissue of mesiodens
	2018

[21]	Regulation of early growth and antioxidant defense mechanism of sweet basil seedlings in response to nutrition
	2017

Journals Menu

Follow SCIRP

	+1 323-425-8868
	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Journals Menu

Home

About SCIRP

Service

Policies